Hyperdopaminergia (elevations in D2/D3 receptor availability) was proposed to underline manic episodes, while increased dopamine transporter (DAT), resulting in reduced dopaminergic function, was suggested for depressive episodes. Here, SLC6A3 is linked to manic or hypomanic episode.